Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230

Journal Article · · Immunity
 [1];  [2];  [2];  [2];  [2];  [1];  [1];  [3];  [3];  [2];  [4];  [4];  [4];  [4];  [5];  [6];  [7];  [8];  [7];  [3] more »;  [5];  [5];  [2];  [2];  [9] « less
  1. Hospital for Sick Children Research Institute, Toronto, ON (Canada)
  2. Radboud Univ., Nijmegen (Netherlands)
  3. TropIQ Health Sciences, Nijmegen (Netherlands)
  4. AbCellera Biologics Inc., Vancouver, BC (Canada)
  5. PATH Malaria Vaccine Initiative, Washington, DC (United States)
  6. Infectious Disease Research Collaboration, Kampala (Uganda)
  7. Univ. of California, San Francisco, CA (United States)
  8. Stanford Univ., CA (United States)
  9. Hospital for Sick Children Research Institute, Toronto, ON (Canada); Univ. of Toronto, ON (Canada)
Pfs230 is essential for Plasmodium falciparum transmission to mosquitoes and is the protein targeted by the most advanced malaria-transmission-blocking vaccine candidate. Prior understanding of functional epitopes on Pfs230 is based on two monoclonal antibodies (mAbs) with moderate transmission-reducing activity (TRA), elicited from subunit immunization. Here, we screened the B cell repertoire of two naturally exposed individuals possessing serum TRA and identified five potent mAbs from sixteen Pfs230 domain-1-specific mAbs. Structures of three potent and three low-activity antibodies bound to Pfs230 domain 1 revealed four distinct epitopes. Highly potent mAbs from natural infection recognized a common conformational epitope that is highly conserved across P. falciparum field isolates, while antibodies with negligible TRA derived from natural infection or immunization recognized three distinct sites. Our study provides molecular blueprints describing P. falciparum TRA, informed by contrasting potent and non-functional epitopes elicited by natural exposure and vaccination.
Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
Bill & Melinda Gates Foundation; European Research Council (ERC); National Institutes of Health (NIH); USDOE Office of Science (SC), Basic Energy Sciences (BES). Scientific User Facilities (SUF)
Grant/Contract Number:
AC02-06CH11357
OSTI ID:
2423565
Journal Information:
Immunity, Journal Name: Immunity Journal Issue: 2 Vol. 56; ISSN 1074-7613
Publisher:
Cell PressCopyright Statement
Country of Publication:
United States
Language:
English

References (76)

The H3 loop of antibodies shows unique structural characteristics journal April 2017
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial journal May 2021
Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults journal November 2022
Multimeric Epitope-Scaffold HIV Vaccines Target V1V2 and Differentially Tune Polyfunctional Antibody Responses journal July 2019
Malaria Vaccines: Recent Advances and New Horizons journal July 2018
Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers journal May 2014
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches journal June 2017
Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization journal August 2018
Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responses journal September 2022
Expression and purification optimization of an N-terminal Pfs230 transmission-blocking vaccine candidate journal August 2019
Assessment of the impact of manufacturing changes on the physicochemical properties of the recombinant vaccine carrier ExoProtein A journal September 2019
Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes journal April 1989
Malaria transmission blocked by immunisation with gametes of the malaria parasite journal September 1976
A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains journal May 1988
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 journal November 2011
Proof of principle for epitope-focused vaccine design journal February 2014
Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape journal October 2012
The I-TASSER Suite: protein structure and function prediction journal December 2014
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120 journal May 2013
Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding journal November 2017
Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity journal February 2018
Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45 journal October 2018
Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25 journal September 2019
Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum journal February 2021
A human monoclonal antibody blocks malaria transmission and defines a highly conserved neutralizing epitope on gametes journal March 2021
Malaria vaccines since 2000: progress, priorities, products journal June 2020
Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoes journal August 2021
Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaques journal December 2021
Elucidating functional epitopes within the N-terminal region of malaria transmission blocking vaccine antigen Pfs230 journal January 2022
Highly accurate protein structure prediction with AlphaFold journal July 2021
Persistent Plasmodium falciparum infections enhance transmission-reducing immunity development journal November 2021
Structure and function of a malaria transmission blocking vaccine targeting Pfs230 and Pfs230-Pfs48/45 proteins journal July 2020
Improved protein structure prediction by deep learning irrespective of co-evolution information journal May 2021
A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes journal December 2015
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine journal November 2015
Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention journal September 2021
Structural models for the protein family characterized by gamete surface protein Pfs230 of Plasmodium falciparum journal September 2005
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9 journal February 2013
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen journal August 2017
Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230 journal July 2016
Transmission-Blocking Vaccines: Harnessing Herd Immunity for Malaria Elimination journal January 2021
Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito. journal November 1985
A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data journal September 2011
MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets journal March 2016
Phaser crystallographic software journal July 2007
XDS journal January 2010
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
Features and development of Coot journal March 2010
How good are my data and what is the resolution? journal June 2013
Malaria transmission-blocking antigen, Pfs230, mediates human red blood cell binding to exflagellating male parasites and oocyst production journal August 2006
Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization journal July 2021
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 journal July 2010
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding journal July 2011
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus journal October 2013
HIV-1 neutralizing antibodies induced by native-like envelope trimers journal June 2015
De novo protein design enables the precise induction of RSV-neutralizing antibodies journal May 2020
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab journal February 2020
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation journal February 2020
Binding mechanisms of therapeutic antibodies to human CD20 journal August 2020
Accurate prediction of protein structures and interactions using a three-track neural network journal July 2021
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates journal May 2021
Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers journal May 2017
Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody journal December 2015
Guiding the Immune Response against Influenza Virus Hemagglutinin toward the Conserved Stalk Domain by Hyperglycosylation of the Globular Head Domain journal October 2013
Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent journal February 1995
Pfs230 yields higher malaria transmission–blocking vaccine activity than Pfs25 in humans but not mice journal April 2021
The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate journal November 2019
An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples journal February 2021
A Research Agenda to Underpin Malaria Eradication journal January 2011
Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study journal November 2020
Profiling the Quality and Quantity of Naturally Induced Antibody Responses Against Pfs230 and Pfs48/45 Among Non-Febrile Children Living in Southern Ghana: A Longitudinal Study journal November 2021
Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum journal June 2019
Heterologous Expression and Evaluation of Novel Plasmodium falciparum Transmission Blocking Vaccine Candidates journal June 2022
The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies. journal December 1987
Malaria Transmission, Infection, and Disease at Three Sites with Varied Transmission Intensity in Uganda: Implications for Malaria Control journal May 2015
Collaboration gets the most out of software journal September 2013